Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report

Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which has provided seed funding for its development, on Tuesday.

Leave a Reply

Your email address will not be published. Required fields are marked *